These findings together indicate that gut microbiota‐dependent type 1 IFN signalling may up‐regulate the expression of TRANK1 and further damaged the integrity of the BBB, thus increasing its permeability and exacerbating the neuroinflammatory basis of BD (Figure 1). The gene discussed is TRANK1; the disease is Behcet disease.